EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Association of remnant cholesterol with cardiovascular disease events in patients with diabetes: a dose-response systematic review and meta-analysis of adjusted models

Reza Eshraghi, Ashkan Bahrami, Mohammadreza Kosari, Kimia Vakili Md-Mph, Ali Keyhani, Pouya Ebrahimi, Ehsan Amini-Salehi, Reza Amani-Beni, Saeed Afkhami, Mohammad Sepehr Yazdani, Salman Bashzar, Shehroze Tabassum und 3 weitere

Nutrition, Metabolism and Cardiovascular Diseases · 2026

DOI: 10.1016/j.numecd.2026.104764 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Nutrition, Metabolism and Cardiovascular Diseases, 2026. Verfasst von Reza Eshraghi und 14 weiteren Autor:innen. Beteiligte Einrichtung: Social Determinants of Health Research Center, Isfahan University of Medical Sciences, Isfahan, Iran. Electronic address: Eshraghi.rza@gmail.com. Hauptthemen laut MEDLINE: Cholesterol, Cardiovascular Diseases, Triglycerides, Dyslipidemias. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Isfahan University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIMS: This review aimed to examine the dose-response relationship between remnant cholesterol (RC) levels and CVD events in individuals with diabetes as well as high-to-low status of RC levels, highlighting its potential clinical significance. DATA SYNTHESIS: This systematic review and meta-analysis followed the PRISMA guidelines and the PICO framework. The protocol was registered in PROSPERO (CRD420251031888). A comprehensive search was conducted up to April 10, 2025. Outcomes were pooled using random-effects models, and dose-response relationships were assessed with restricted cubic splines (RCS). Our meta-analysis pooled data from 2,276,576 participants included in fifteen studies. Higher remnant cholesterol compared with referenced level was associated with higher cardiovascular events, including: MACE, as defined including non-fatal myocardial infarction (MI), stroke, CVD death, and revascularization (Pooled HR = 1.64 (95% CI: 1.16-2.30, I2 = 91.7%)), revascularization (Pooled HR = 1.44 (95% CI: 1.22-1.70)), and ischemic stroke (Pooled HR = 1.12 (95% CI: 1.01-1.24)). Relationship with all-cause mortality, non-fatal MI, and atherosclerotic cardiovascular disease (ASCVD) was not significant. Dose-response analysis with RCS model revealed a statistically significant relationship between remnant cholesterol and the risk of MACE (p < 0.0001), myocardial infarction (p = 0.0008) ischemic stroke (p < 0.05). CONCLUSIONS: Higher remnant cholesterol levels are associated with increased cardiovascular risk in diabetes. The dose-response analysis supports its role as an important biomarker for cardiovascular risk, suggesting a potential for clinical use alongside traditional lipid markers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholesterolCardiovascular DiseasesTriglyceridesDyslipidemiasDiabetes MellitusHumansBiomarkersRisk AssessmentFemaleMaleAgedMiddle AgedPrognosisHeart Disease Risk FactorsAdultAged, 80 and overUp-RegulationRisk FactorsLipoproteins

Stichwörter der Autor:innen

Cardiovascular diseaseDose-responseMeta-analysisRemnant cholesterolType 2 diabetes

Substanzen

CholesterolBiomarkersTriglyceridesremnant-like particle cholesterolLipoproteins

Autor:innen und Institutionen

  • Social Determinants of Health Research Center, Isfahan University of Medical Sciences, Isfahan, Iran. Electronic address: Eshraghi.rza@gmail.com.
  • Kashan University of Medical Sciences, Isfahan, Iran. Electronic address: ashkanbahrami1998@gmail.com.
  • Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Electronic address: mh.reza.kosari@gmail.com.
  • Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: kimiavakili1998@gmail.com.
  • Kashan University of Medical Sciences, Isfahan, Iran. Electronic address: keyhani.ali799@gmail.com.
  • Department of Cardiology, Queen Elizabeth Hospital Birmingham, Birmingham, B15 2TH, UK. Electronic address: Pouyaebrahimi1992@gmail.com.

Förderung

  • Isfahan University of Medical Sciences

Zitieren

APA

Eshraghi, R., Bahrami, A., Kosari, M., Md-Mph, K. V., Keyhani, A., Ebrahimi, P., Amini-Salehi, E., Amani-Beni, R., Afkhami, S., Yazdani, M. S., Bashzar, S., Tabassum, S., Minhas, A. M. K., Al-Hijji, M., & Md-Mph, H. S. (2026). Association of remnant cholesterol with cardiovascular disease events in patients with diabetes: a dose-response systematic review and meta-analysis of adjusted models. Nutrition, Metabolism and Cardiovascular Diseases. https://doi.org/10.1016/j.numecd.2026.104764

Vancouver

Eshraghi R, Bahrami A, Kosari M, Md-Mph KV, Keyhani A, Ebrahimi P, et al. Association of remnant cholesterol with cardiovascular disease events in patients with diabetes: a dose-response systematic review and meta-analysis of adjusted models. Nutrition, Metabolism and Cardiovascular Diseases. 2026. doi:10.1016/j.numecd.2026.104764

BibTeX
@article{Eshraghi2026,
  author = {Eshraghi, Reza and Bahrami, Ashkan and Kosari, Mohammadreza and Md-Mph, Kimia Vakili and Keyhani, Ali and Ebrahimi, Pouya and Amini-Salehi, Ehsan and Amani-Beni, Reza and Afkhami, Saeed and Yazdani, Mohammad Sepehr and Bashzar, Salman and Tabassum, Shehroze and Minhas, Abdul Mannan Khan and Al-Hijji, Mohammed and Md-Mph, Hamidreza Soleimani},
  title = {Association of remnant cholesterol with cardiovascular disease events in patients with diabetes: a dose-response systematic review and meta-analysis of adjusted models},
  journal = {Nutrition, Metabolism and Cardiovascular Diseases},
  year = {2026},
  doi = {10.1016/j.numecd.2026.104764}
}
Kostenlos starten →